2Wang G, Yang H, Chen K. Osteoporotic vertebral compression fractures with an intravertebral cleft treated by percutaneous balloon kyphoplasty[ J]. J Bone Joint Surg Br, 2010, 92:1553 - 1557.
3Mao H, Zou J, Geng D, et al. Osteoporotic vertebral fractures without compression : key factors of diagnosis and initial outcome oftreatment with cement augmentation [ J ]. Neuroradiology, 2012, 54:1137 - 1143.
4Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis [ J ]. N Engl J Med, 2007, 356 : 1809 - 1822.
5Black DM, Reid IR, Boonen S, et al. The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT) [ J]. J Bone Miner Res ,2012,27:243 - 254.
6Black DM, Reid 1R, Cauley JA, et al. The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT) [ J]. J Bone Miner Res,2015,30:934 - 944.
7Lyles KW, Col6n-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture[ J]. N Engl J Med ,2007,357 : 1799 - 1809.
8Black DM, Schwartz AV, Ensrud KE, et al. Effects of continuing or stopping alendronate after 5 years of treatment : the Fracture Intervention Trial Long-term Extension ( FLEX ) : a randomized trial[ J]. JAMA,2006 ,296 :2927 - 2938.
9Bone HG, Hosking D, Devogelaer JP, et al. Ten years' experience with alendronate for osteoporosis in postmenopausal women[J]. N Engl J Med ,2004,350 : 1189 - 1199.
10Zhang ZL, Liao EY, Xia WB, et al. Alendronatc sodium/vitamin D3 combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-eontrolled study with a 6-month extension [J]. OsteoporosInt,2015 ,26 :2365 - 2374.
